IL13RA2 and metastatic colorectal cancer: It was reported that IL13Rα2 was overexpressed in metastatic colorectal cancer and inhibition of IL13 binding to IL13Rα2 showed the therapeutic activity in colorectal cancer by reducing metastatic spread [13].